Camilia Martin
Weill Medical College of Cornell University, NY·Medicine & Clinical Research
Babies born very early lose the steady supply of nutrients and protection they would have received in the womb, and breast milk is central to their care. That milk can also carry risks.
- Fields
Medicine & Clinical Research
Microbiology & Immunology
Biochemistry
- Topics
preterm infants
neonatology
cytomegalovirus
- Grants
- 2 known grants, through Jul 2027
What they work on
- Measure the pharmacokinetics and virus-blocking power of an anti-CMV neutralizing antibody added to CMV-positive human milk, testing whether it can reduce infection and immune cell infiltration.
- Determine how cytomegalovirus reactivating in the breast changes the human milk lipidome, the full set of milk fats, and whether CMV-positive milk affects preterm infants' health outcomes.
- Identify how combined DHA and ARA feeding in extremely preterm infants changes fatty acid metabolism, including production of specialized pro-resolving mediators and oxylipins, in a 280-infant randomized trial.
- Determine how DHA and ARA supplementation from birth to 36 weeks postmenstrual age changes circulating markers of inflammation, organ development and organ integrity in extremely preterm infants.
More about the research
Feeding these infants safely and effectively is the shared theme of two projects: one on a virus that can pass through breast milk, and one on fats that the developing brain and eyes need.
Why it matters
Preterm infants depend on breast milk but are vulnerable to CMV passed through it and to missing fatty acids they would have received before birth. Adding neutralizing antibodies to CMV-positive milk could lower the risk of infection while keeping the nutrition of breast milk. The fatty acid trial could guide safer, more rational DHA and ARA feeding. Both projects aim to identify biomarkers for future clinical trials.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Ginger Milne
University of Alabama at Birmingham, AL·Pharmacology
Identify how four specialized pro-resolving lipid mediators (RvE4, RvD1, RvD5 and maresin 2), molecules that help end inflammation, are chemically transformed using a laboratory model of human metabolism.
Zhenjia Wang
University at Buffalo, NY·Biomedical Engineering
Engineer liposomes built from ionizable cationic lipids to deliver docosahexaenoic acid (DHA), an omega-3 fatty acid, into neutrophils and release it efficiently once inside.
Matthew Harer
University of Wisconsin-Madison, WI·Medicine & Clinical Research
Test in a randomized trial whether an extra caffeine dose of 10 or 20 mg/kg raises kidney oxygen levels more than placebo in preterm infants under 30 weeks' gestation with low kidney oxygen measured by near-infrared spectroscopy.
The school
Weill Medical College of Cornell University: 35 labs on PI Pages, $1.6B a year on research, 59 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.